Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 3.97 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 7:40 AM 11/3/14 All times are local (Market data is delayed by at least 15 minutes).

jupiter bioscience ltd (JPO) Snapshot

Open
--
Previous Close
3.97
Day High
--
Day Low
--
52 Week High
08/27/14 - 3.97
52 Week Low
08/27/14 - 3.97
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
7.28
Shares Outstanding
61.7M
EX-Date
09/23/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for JUPITER BIOSCIENCE LTD (JPO)

Related News

No related news articles were found.

jupiter bioscience ltd (JPO) Related Businessweek News

No Related Businessweek News Found

jupiter bioscience ltd (JPO) Details

Jupiter Bioscience Limited manufactures drug intermediates, specialty and fine chemicals, bulk drugs, and nutraceuticals primarily in India. The company offers aminoacids and its derivatives, including Fmoc-, Boc-, and Z-protected aminoacids, as well as side chain protected aminoacids. It also provides formulations, such as Leusven for infertility treatment and prostrate cancer; Glosur, a peptide based anti ageing cream; Revitress, a hair growth gel; Isosven for osteoporosis; Rubicarb for anaemia; Winomcar, an antioxidant; Co-enzyme Q10, a supplement with chemotherapy drugs; Methylcobalamin, a supplement for vitamin B12 deficiency; Imatinib for the treatment of leukemias and gastrointestinal stromal tumors; Aromataz to treat breast cancer after surgery and for metastases in postmenopausal women; Gravigest, a C-21 steroid hormone; and Sven HCG, a glycoprotein hormone. In addition, the company offers Svenpar, Paragesics, and Svengin to reduce pain and fever; Svenmet for the treatment of type 2 diabetes; and Parafenac used to reduce pain. Further, it provides un-natural amino acids, beta amino acids, and enzymes; and peptides for cardiovascular disorders, tissue repair, cosmetics, vaccines, and anti-infective agents, as well as offers 4-Chloro Resorcinol, ECCP Alanine, Dibenzyl Glycyl Salicylamide, and 3 4 5 Trimethoxy Benzaldehyde. Additionally, the company offers various contract research and development services; and custom manufacturing services. It serves pharmaceutical companies, biotechnology companies, research and development institutions, research companies, and medical schools. The company exports its products to Bangladesh, Belgium, England, France, Germany, Ghana, Iran, Japan, Kenya, Latin America, Pakistan, Switzerland, and the United Kingdom. Jupiter Bioscience Limited was founded in 1985 and is based in Secunderabad, India.

Founded in 1985

jupiter bioscience ltd (JPO) Top Compensated Officers

Chairman, Managing Director, Member of Audit ...
Total Annual Compensation: --
Compliance Officer and Assistant Manager
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JPO:IN 3.97 INR 0.00

JPO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JPO.
View Industry Companies
 

Industry Analysis

JPO

Industry Average

Valuation JPO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JUPITER BIOSCIENCE LTD, please visit www.jupiterbioscience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.